Background. A phase III randomized comparison of radiotherapy alone versus combination chemotherapy and concurrent continuous-course radiotherapy was performed at the Cleveland Clinic Foundation. Methods. Between March 1990 and June 1995, 100 patients with resectable stage III and IV squamous cell
Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer
β Scribed by Pierre Lavertu; David J. Adelstein; Jerrold P. Saxton; Michelle Secic; John R. Wanamaker; Isaac Eliachar; Benjamin G. Wood; Marshall Strome
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 94 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Background. Treating the neck after organpreservation treatment with radiotherapy or chemoradiotherapy can be problematic.
Methods. To develop management guidelines, we reviewed the results of a 100-patient phase-3 trial that had compared outcome after radiotherapy alone with outcome after chemoradiotherapy for head and neck cancer. Patients were randomly assigned to receive radiotherapy alone or concurrent chemoradiotherapy. After completing therapy, patients were reassessed, and surgery was recommended for persistent disease at the primary site or neck and for all patients with stage N2-3 neck nodes regardless of clinical response.
Results. Of the 47 patients with stage N0-1, 43 had a complete response (CR); of the 18 N1 patients, all but 4 had a CR.
π SIMILAR VOLUMES
The current study presents mature results from a Phase III randomized trial comparing radiation therapy and concurrent chemoradiotherapy in patients with resectable American Joint Committee on Cancer Stage III and IV disease.
arino et al.' have performed a meta-analysis using data extracted M from published randomized trials comparing radiotherapy (RT) to RT plus chemotherapy (CT) in Stage IIIA and IIIB unresectable nonsmall cell lung cancer (NSCLC). They identified 14 trials published between 1980 and 1994. The odds rat
## BACKGROUND. The authors previously have found that in patients with locally advanced squamous cell carcinoma of the head and neck (SCC-HN), alternating chemoradiotherapy (ALT) was superior to low-total-dose conventional radiotherapy alone. The purpose of this randomized trial was to compare the